First prospective clinical trial of adaptive radiotherapy for head and neck cancer patients

Researchers at the Feinstein Institute for Medical Research released initial findings from a first-of-a-kind clinical trial in adaptive radiotherapy for head and neck cancer. The trial, sponsored by the National Cancer Institute, showed most patients benefited from only one or at most two adaptive radiotherapy treatments. These findings were released online in advance of publication in the International Journal of Radiation Oncology Biology Physics.